Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
Research To Practice | Oncology Videos · Dr. Neil Love
May 29, 202550m 50s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring an interview with Dr Rafael Fonseca, including the following topics:
- Safe management of bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for patients with multiple myeloma (MM) (0:00)
- Sequencing bispecific antibodies and CAR T-cell therapy (10:40)
- Available data with and potential future clinical integration of belantamab mafodotin in the management of MM (16:03)
- Optimizing maintenance therapy for patients with MM (31:11)
- Novel management strategies for smoldering myeloma (36:29)
- Role of anti-CD38 antibodies in the up-front management of MM (41:41)
- Available data with cereblon E3 ligase modulatory drugs for MM (47:45)